![Warner Biddle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Warner Biddle
Chief Executive Officer at
KYVERNA THERAPEUTICS, INC.
Net worth: - $ as of 31/05/2026
Profile
Warner Biddle currently works at Kyverna Therapeutics, Inc., as Chief Executive Officer & Director from 2024.
Mr. Biddle also formerly worked at Genentech, Inc., as Vice President-Sales & Marketing and Kite Pharma, Inc., as Senior Vice President & Global Head-Commercial.
Mr. Biddle received his undergraduate degree from the University of Saskatchewan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Warner Biddle active positions
| Companies | Position | Start |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Chief Executive Officer | 16/09/2024 |
Former positions of Warner Biddle
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | - |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Training of Warner Biddle
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of Saskatchewan
 University of Saskatchewan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Warner Biddle
